English

Eligibility Colorectal Cancer NCT00079872

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
the patient must have:
Description

ID.1

Data type

boolean

histologic or cytologic diagnosis of adenocarcinoma of the colon or rectum.
Description

Adenocarcinoma of colon | Adenocarcinoma of rectum

Data type

boolean

Alias
UMLS CUI [1]
C0338106
UMLS CUI [2]
C0149978
performance status of 0 to 2 on the ecog performance status scale.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
standard postoperative adjuvant radiation therapy for rectal cancer is allowed.
Description

adjuvant postoperative radiation therapy Rectal Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C3162256
UMLS CUI [1,2]
C0007113
locally advanced or metastatic disease.
Description

Locally Advanced Malignant Neoplasm | Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1]
C0677984
UMLS CUI [2]
C0027627
must be 18 years of age.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
the patient must not have:
Description

ID.7

Data type

boolean

received prior chemotherapy for advanced disease. prior adjuvant therapy, including 5-fu, is allowed if it has been more than 12 months since the last treatment.
Description

Prior Chemotherapy advanced disease | Prior Adjuvant Therapy | Fluorouracil

Data type

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0679246
UMLS CUI [2]
C1514456
UMLS CUI [3]
C0016360
received prior treatment with irinotecan in the adjuvant setting.
Description

irinotecan | Prior Adjuvant Therapy

Data type

boolean

Alias
UMLS CUI [1]
C0123931
UMLS CUI [2]
C1514456
are unable to take vitamin b12 or folic acid.
Description

Able to take medication Vitamin B 12 | Able to take medication Folic Acid

Data type

boolean

Alias
UMLS CUI [1,1]
C4075001
UMLS CUI [1,2]
C0042845
UMLS CUI [2,1]
C4075001
UMLS CUI [2,2]
C0016410
are unable to interrupt aspirin, other nonsteroidal anti-inflammatory drugs, or cox-2 inhibitors for a 5-day period.
Description

Aspirin Interrupt Unable | Non-Steroidal Anti-Inflammatory Agents Interrupt Unable | Cyclooxygenase 2 Inhibitors Interrupt Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0004057
UMLS CUI [1,2]
C0443239
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C0003211
UMLS CUI [2,2]
C0443239
UMLS CUI [2,3]
C1299582
UMLS CUI [3,1]
C1257954
UMLS CUI [3,2]
C0443239
UMLS CUI [3,3]
C1299582
have a second primary malignancy except carcinoma in situ of the cervix or nonmelanomatous skin cancer, unless that prior malignancy was diagnosed and definitively treated at least 5 years previously with no subsequent evidence of recurrence.
Description

Second Primary Cancer | Carcinoma in situ of uterine cervix | Skin carcinoma | Malignant Neoplasm Previous Treated Definitive | Recurrence Evidence

Data type

boolean

Alias
UMLS CUI [1]
C0751623
UMLS CUI [2]
C0851140
UMLS CUI [3]
C0699893
UMLS CUI [4,1]
C0006826
UMLS CUI [4,2]
C0205156
UMLS CUI [4,3]
C1522326
UMLS CUI [4,4]
C0443196
UMLS CUI [5,1]
C0034897
UMLS CUI [5,2]
C3887511
Back to the top of the page

Similar models

Eligibility Colorectal Cancer NCT00079872

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
the patient must have:
boolean
Adenocarcinoma of colon | Adenocarcinoma of rectum
Item
histologic or cytologic diagnosis of adenocarcinoma of the colon or rectum.
boolean
C0338106 (UMLS CUI [1])
C0149978 (UMLS CUI [2])
ECOG performance status
Item
performance status of 0 to 2 on the ecog performance status scale.
boolean
C1520224 (UMLS CUI [1])
adjuvant postoperative radiation therapy Rectal Carcinoma
Item
standard postoperative adjuvant radiation therapy for rectal cancer is allowed.
boolean
C3162256 (UMLS CUI [1,1])
C0007113 (UMLS CUI [1,2])
Locally Advanced Malignant Neoplasm | Neoplasm Metastasis
Item
locally advanced or metastatic disease.
boolean
C0677984 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
Age
Item
must be 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.7
Item
the patient must not have:
boolean
Prior Chemotherapy advanced disease | Prior Adjuvant Therapy | Fluorouracil
Item
received prior chemotherapy for advanced disease. prior adjuvant therapy, including 5-fu, is allowed if it has been more than 12 months since the last treatment.
boolean
C1514457 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
C1514456 (UMLS CUI [2])
C0016360 (UMLS CUI [3])
irinotecan | Prior Adjuvant Therapy
Item
received prior treatment with irinotecan in the adjuvant setting.
boolean
C0123931 (UMLS CUI [1])
C1514456 (UMLS CUI [2])
Able to take medication Vitamin B 12 | Able to take medication Folic Acid
Item
are unable to take vitamin b12 or folic acid.
boolean
C4075001 (UMLS CUI [1,1])
C0042845 (UMLS CUI [1,2])
C4075001 (UMLS CUI [2,1])
C0016410 (UMLS CUI [2,2])
Aspirin Interrupt Unable | Non-Steroidal Anti-Inflammatory Agents Interrupt Unable | Cyclooxygenase 2 Inhibitors Interrupt Unable
Item
are unable to interrupt aspirin, other nonsteroidal anti-inflammatory drugs, or cox-2 inhibitors for a 5-day period.
boolean
C0004057 (UMLS CUI [1,1])
C0443239 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C0443239 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
C1257954 (UMLS CUI [3,1])
C0443239 (UMLS CUI [3,2])
C1299582 (UMLS CUI [3,3])
Second Primary Cancer | Carcinoma in situ of uterine cervix | Skin carcinoma | Malignant Neoplasm Previous Treated Definitive | Recurrence Evidence
Item
have a second primary malignancy except carcinoma in situ of the cervix or nonmelanomatous skin cancer, unless that prior malignancy was diagnosed and definitively treated at least 5 years previously with no subsequent evidence of recurrence.
boolean
C0751623 (UMLS CUI [1])
C0851140 (UMLS CUI [2])
C0699893 (UMLS CUI [3])
C0006826 (UMLS CUI [4,1])
C0205156 (UMLS CUI [4,2])
C1522326 (UMLS CUI [4,3])
C0443196 (UMLS CUI [4,4])
C0034897 (UMLS CUI [5,1])
C3887511 (UMLS CUI [5,2])
Back to the top of the page